Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.

Volume 3 (2006), Issue 10 (October)

1. Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage.
   Hepatology, 44(4): 857-64. [Abstract] [Full-text]
2. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
   Hepatology, 44(4): 844-9. [Abstract] [Full-text]
3. Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis.
   Hepatology, 44(4): 823-35. [Abstract] [Full-text]
4. Hemodynamic response-guided therapy for prevention of variceal rebleeding: an uncontrolled pilot study.
   Hepatology, 44(4): 806-12. [Abstract] [Full-text]
5. Impaired 11 beta-hydroxysteroid dehydrogenase contributes to renal sodium avidity in cirrhosis: hypothesis or fact?
   Hepatology, 44(4): 795-801. [Abstract] [Full-text]
6. Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection.
   Hepatology, 44(4): 925-35. [Abstract] [Full-text]
7. Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease.
   Gut, 55(11): 1650-60. [Abstract] [Full-text]
8. Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats.
   Gut, 55(11): 1606-16. [Abstract] [Full-text]
9. Characterization of plasma proteome in biliary atresia.
   Clin Chim Acta, 375(1): 104-9. [Abstract] [Full-text]

© 2004-2008 Liver Cirrhosis Research Today. All Rights Reserved.